Current Status of Alzheimer’s Disease and Pathological Mechanisms Investigating the Therapeutic Molecular Targets
Authors:
- 1 July 2023
- journal article
- review article
- Published by Bentham Science Publishers Ltd. in Current Molecular Medicine
- Vol. 23 (6) , 492-508
Abstract
Alzheimer's disease (AD) is a psychological, biological, or developmental disorder that affects basic mental functioning. AD is generally affiliated with marked discomfort and impaired social, professional, or other crucial aspects of life. AD is predominant worldwide, but a disparity in prevalence is observed amongst nations. Around 3/4 of people with Alzheimer's disease are from underdeveloped nations, which receive only 1/10th of global mental health resources. Residents of each community and age category share their presence in the overall load of AD. AD is a multifactorial disease impacted by numerous environmental, genetic, and endogenous elements. Heteromorphic interactive downstream cascades, networks, and molecular mechanisms (inflammation and immune network, cholinergic deficit, lipid transit, endocytosis, excitotoxicity, oxidative stress, amyloid and tau pathology, energy metabolism, neuron and synapse loss, and cell death) have been isolated, imparting a non-dissociative contribution in pathogenesis of AD. In the CNS, the structural organization of cholinergic neurons can give a novel insight into the mechanism of new learning. The alleviation of central cholinergic transposal following destruction in the basal forebrain cholinergic neurons precipitates a decline in neurocognitive symptoms visible in AD patients. The brain of patients suffering from AD exhibits plaques of aggregated amyloid-β and neurofibrillary tangles containing hyperphosphorylated tau protein. Amyloid-β triggers cholinergic loss by modulation of calcium and generation of cell-damaging molecules such as nitric oxide and reactive oxygen species intermediates. The present review focuses on the pathogenic mechanisms related to stages, diagnosis, and therapeutic approaches involved in AD.Keywords
This publication has 101 references indexed in Scilit:
- Intracerebroventricular administration of an insulin analogue recovers STZ-induced cognitive decline in ratsBehavioural Brain Research, 2013
- Oxidative Stress, Mitochondrial Dysfunction, and AgingJournal of Signal Transduction, 2012
- Acetylcholine as a Neuromodulator: Cholinergic Signaling Shapes Nervous System Function and BehaviorNeuron, 2012
- Rutin prevents cognitive impairments by ameliorating oxidative stress and neuroinflammation in rat model of sporadic dementia of Alzheimer typeNeuroscience, 2012
- Elevation of glutathione as a therapeutic strategy in Alzheimer diseaseBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2012
- Design of β-Amyloid Aggregation Inhibitors from a Predicted Structural MotifJournal of Medicinal Chemistry, 2012
- Brain oxidative stress: Detection and mapping of anti-oxidant marker ‘Glutathione’ in different brain regions of healthy male/female, MCI and Alzheimer patients using non-invasive magnetic resonance spectroscopyBiochemical and Biophysical Research Communications, 2012
- Activation of α‐secretase cleavageJournal of Neurochemistry, 2011
- Increased NF-κB signalling up-regulates BACE1 expression and its therapeutic potential in Alzheimer's diseaseInternational Journal of Neuropsychopharmacology, 2011
- Inflammation in Alzheimer's disease: relevance to pathogenesis and therapyAlzheimer's Research & Therapy, 2010